Published 2 days ago • loading... • Updated 2 days ago

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

Summary by The Manila Times

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of an underwritten public offering of 24,242,425 shares of its common stock at a public offering price of $8.25 per share. The gross proceeds to Dyne from the offering, before deducting underwriti…

3 Articles

All

Left

Center

Right

Enid News & Eagle

Reposted by

The Manila Times

Lean Left

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

2 days ago

Read Full Article

stocktitan.net

Neuromuscular Disease Pioneer Dyne Therapeutics Secures Massive $200M Stock Offering: Key Details Revealed

Clinical-stage biotech Dyne prices 24.2M shares at $8.25 each to advance neuromuscular disease treatments. See how this capital raise strengthens their pipeline.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year